Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05904886 |
|---|---|
| Brief Title: | A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (IMbrave152) (SKYSCRAPER-14) |
| First Submitted : | May 23, 2023 |
| First Submitted that Met QC Criteria : | June 14, 2023 |
| First Posted : | June 15, 2023 |
| Last Update Submitted that Met QC Criteria : | April 11, 2024 |
| Last Update Posted : | April 12, 2024 |